MassRoots

MAY 12, 2020

A Brief History. It all began in 2015 when Georgia lawmakers approved legislation to allow registered medical marijuana patients in the state to possess and use up to 20 fluid ounces of low-THC cannabis oil.

Oil 53

Oil Programs Access Patients 53

Cannabis Law Report

APRIL 20, 2019

The legislation allows the in-state production and sale of the marijuana oil and closes a loophole in a 2015 law that banned growing, buying and selling the drug but allowed certain patients to possess it. History has been made in Georgia, said Corey Lowe, who has been using the oil to contain her teenage daughters seizures since 2014.

Access 45

Access Oil Patients Law 45

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. The Texas Compassionate Use Program (TCUP) represents the Lone Star State’s cautious foray into the realm of medical marijuana.

Law 52

Law Clinical Trials Dispensary Programs 52

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. It also has an extensive and diverse history of medicinal use. Refractory paediatric epilepsy. 2015 ; Kaiser 2011 ; Mortensen et al. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

MAY 6, 2022

Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products. Examples of sellers’ language the FDA views as illegal are the following: “Our line of …CBD oil … is great for insomnia, epilepsy, MS, schizophrenia, and chronic pain.”.

THC 52

THC CBD Media Food 52

Cannabis Law Report

SEPTEMBER 23, 2019

Cannabis use, both medically and recreationally, is prevalent throughout history. 7 While the lifetime use remains relatively stable for this cohort, from 2015-2017, past year and past month use increased 2.7% In 2015, Whiting, et al, performed a meta-analysis and systematic review of research on the medical use of cannabis.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

OCTOBER 24, 2019

We’re witnessing history being made many times over, as the Green Wave of decriminalisation and legalisation of Cannabis rushes across the World. It will allow for regulated, supervised and limited access for our sick citizens especially those with cancer, HIV/ AIDS, glaucoma, and epilepsy. The oils can be legally imported.

Law 45

Law Medicine Decriminalization Oil 45

Greencamp

DECEMBER 4, 2018

Over the course of history, numerous cultures have been using cannabis for medicinal reasons. Fuss J, Steinle J, Bindila L, Auer MK, Kirchherr H, Lutz B, Gass P; A runner’s high depends on cannabinoid receptors in mice; 2015; 112(42). Endocannabinoid system discovery. Depression. Post-traumatic Stress Disorder (PTSD).

Cannabinoids 107

Cannabinoids Research and Development Conditions THC 107

Greencamp

AUGUST 16, 2018

Brief history of ALS. The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94

Strains Cannabinoids Research and Development Indica 94

The Cannigma

AUGUST 8, 2022

Several bills have been introduced as far back as 2015 , and more recently in 2021 and 2022 to create a legal medical or adult-use program in Kentucky, but all have failed. Kentucky has a long history of growing industrial hemp dating back to the 1700s. How do people in Kentucky view cannabis?

Law 52

Law Programs Hemp Cannabis 52

StrainConnect

FEBRUARY 8, 2019

From cancer(11) to epilepsy(12), there seems to be very little that cannabis cannot help with. A 2015 Israeli study found that full-spectrum CBD oil is effective at much lower doses and has a wider therapeutic window than a CBD isolate(17). Endocannabinoids and epilepsy - Science Direct. 2015, Feb.). 2015, Jan.).

Hemp 57

Hemp CBD Cannabinoids Sativa 57

SpeedWeed

MAY 22, 2021

Due to it’s high temporal value, EEG shines at detecting epilepsy, sleep disorders, dementia and any other structural brain disease or disorder. Carhart-Harris 2015): In 2015, Robin L. However it’s the first study in history to look at serotonin receptors and psilocybin influencing the claustrum, and it just happened last year.

Research and Development 52

Research and Development Microdosing Wellness and Beauty Pets 52

Green Relief

MAY 13, 2018

It is the most commonly identified cause of epilepsy among adults. According to a 2015 study in Neurotherapeutics , “Upregulation of CB2 with no changes in CB1 have been found in TBI.”. Martin A Lee is the director of Project CBD and the author of Smoke Signals: A Social History of Marijuana – Medical, Recreational and Scientific.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

It is the most commonly identified cause of epilepsy among adults. According to a 2015 study in Neurotherapeutics , “Upregulation of CB2 with no changes in CB1 have been found in TBI.”. Martin A Lee is the director of Project CBD and the author of Smoke Signals: A Social History of Marijuana – Medical, Recreational and Scientific.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

OCTOBER 26, 2019

doctors, dentists, radiographers, nurses, pharmacists and psychologists) for patients who do not fit the Category A definition and where the UTG is not deemed to have an ‘established history of use’ Approval from the TGA is required before the UTG may be accessed. regarding the transition from the 2015 Code).

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45